Page last updated: 2024-08-21

pyrazines and Syndrome

pyrazines has been researched along with Syndrome in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (12.50)	29.6817
2010's	5 (62.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Aguilar-Company, J; Los-Arcos, I; Ruiz-Camps, I	1
Saijo, M	1
Ho, CH; Lo, CP; Tu, MC	1
Adachi, D; Hattori, N; Nakamaki, T; Nakashima, H; Saito, B; Tomoyasu, S	1
O'Connell, C; Schroyens, W; Sykes, DB	2
Korde, N; Kwok, M; Landgren, O	1
Feuerstein, G; Hemmendinger, R; Lichtenberg, D; Zilberman, Y	1

Reviews

2 review(s) available for pyrazines and Syndrome

Article	Year
Risk of infection associated with new therapies for lymphoproliferative syndromes. Medicina clinica, 2020, 02-14, Volume: 154, Issue:3 Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Communicable Disease Control; Humans; Immune Checkpoint Inhibitors; Infections; Lymphoproliferative Disorders; Piperidines; Purines; Pyrazines; Quinazolinones; Risk; Rituximab; Sulfonamides; Syndrome	2020
Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:10 Topics: Aged, 80 and over; Amides; Animals; Antiviral Agents; Bunyaviridae Infections; China; Female; Humans; Japan; Male; Mice; Mice, Knockout; Middle Aged; Mortality; Phlebovirus; Pyrazines; Republic of Korea; Syndrome; Thrombocytopenia	2018

Article

Year

Risk of infection associated with new therapies for lymphoproliferative syndromes.

Medicina clinica, 2020, 02-14, Volume: 154, Issue:3

Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Immunological; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Communicable Disease Control; Humans; Immune Checkpoint Inhibitors; Infections; Lymphoproliferative Disorders; Piperidines; Purines; Pyrazines; Quinazolinones; Risk; Rituximab; Sulfonamides; Syndrome

2020

Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:10

Topics: Aged, 80 and over; Amides; Animals; Antiviral Agents; Bunyaviridae Infections; China; Female; Humans; Japan; Male; Mice; Mice, Knockout; Middle Aged; Mortality; Phlebovirus; Pyrazines; Republic of Korea; Syndrome; Thrombocytopenia

2018

Other Studies

6 other study(ies) available for pyrazines and Syndrome

Article	Year
Bortezomib-induced posterior reversible encephalopathy syndrome: clinical and imaging features. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:16 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Posterior Leukoencephalopathy Syndrome; Pyrazines; Syndrome	2014
Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma. Leukemia research, 2009, Volume: 33, Issue:4 Topics: Acyclovir; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Cyclosporine; Dexamethasone; Drug Hypersensitivity; Exanthema Subitum; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Prednisone; Pyrazines; Syndrome; Virus Activation	2009
The TEMPI syndrome--a novel multisystem disease. The New England journal of medicine, 2011, Aug-04, Volume: 365, Issue:5 Topics: Adult; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Hydronephrosis; Lymphangiectasis; Male; Middle Aged; Paraproteinemias; Polycythemia; Protease Inhibitors; Pyrazines; Syndrome; Telangiectasis	2011
Bortezomib to treat the TEMPI syndrome. The New England journal of medicine, 2012, May-10, Volume: 366, Issue:19 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Lymphangiectasis; Middle Aged; Paraproteinemias; Polycythemia; Pyrazines; Syndrome; Telangiectasis	2012
Complete and partial responses of the TEMPI syndrome to bortezomib. The New England journal of medicine, 2012, Aug-23, Volume: 367, Issue:8 Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Erythropoietin; Female; Humans; Male; Middle Aged; Paraproteinemias; Polycythemia; Pyrazines; Syndrome; Telangiectasis	2012
Attenuation of the lithium-induced diabetes-insipidus-like syndrome by amiloride in rats. Neuropsychobiology, 1981, Volume: 7, Issue:2 Topics: Amiloride; Animals; Diabetes Insipidus; Lithium; Male; Polyuria; Potassium; Pyrazines; Rats; Sodium; Syndrome; Thirst; Water	1981